Medicine & Life Sciences
Non-alcoholic Fatty Liver Disease
100%
Glucose
94%
Sleep
87%
alpha-2-HS-Glycoprotein
75%
cardiotrophin 1
74%
Glucose Intolerance
74%
Insulin Resistance
71%
Growth Differentiation Factor 15
68%
Fasting
57%
Hedgehog Proteins
56%
Overweight
54%
Obesity
49%
secretogranin III
44%
High Fat Diet
42%
rat PPAR gamma
42%
Liver
40%
Serum
38%
GW9508
38%
Lipopolysaccharides
36%
Prediabetic State
36%
Hyperglycemia
34%
Anti-Obesity Agents
32%
Oleic Acid
32%
Thyroid Gland
32%
Ankle
31%
Population
31%
Nodular Goiter
31%
Glucocorticoids
30%
Graves Ophthalmopathy
30%
Fatty Acids
30%
Arm
29%
Glucagon-Like Peptide-1 Receptor
28%
Unsaturated Fatty Acids
28%
Insulin
28%
Thyrotoxicosis
28%
Amiodarone
27%
Regression Analysis
26%
Hypertension
26%
Manuscripts
25%
Linear Models
25%
Chemical Compounds
Peroxisome Proliferator Activated Receptor Antagonist
47%
Glucagon-Like Peptide-1 Receptor Agonist
43%
Glucose
37%
Hyperglycemic
34%
Velocity
33%
Corticosterone
31%
Hypertensive
30%
Glucocorticoid
28%
Glycemic
28%
Metabolic
27%
Unsaturated Fatty Acid
25%
Lipopolysaccharide
24%
Insulin Derivative
22%
Antiinvasive
19%
Antimetastatic
17%
Antihypertensive Agent
16%
Chemoattractant
16%
Ethanol
14%
Blood Pressure
14%
Protein
13%
Nitrogen Oxide
13%
Lipid
12%
Protective
12%
Cell Viability
11%
Fatty Acid
10%
Antiinflammatory
10%
Stattic
10%
Antineoplastic Agent
9%
Hemoglobin
9%
Adiponectin
8%
Triglyceride
8%
Oil Red O
7%
Molecular Cluster
5%
Dexamethasone
5%
Plasma Level
5%
Superoxide
5%
Reactive Oxygen Metabolite
5%
Body Weight Change
5%
High-Density Lipoprotein Cholesterol
5%